Answers are grounded in this paper and cite their sources.
Examines voriconazole's impact on cell-cycle and differentiation pathways in keratinocytes, suggesting significant implications for cancer risk.
Voriconazole is a second generation triazole antifungal used routinely in the care of solid organ and stem cell transplant recipients to both prevent and treat invasive fungal infections (1) . Voriconazole causes photosensitivity (2) and has been associated with a dose-dependent increased risk of developing cutaneous squamous cell carcinoma (cSCC).(3) Possible mechanisms suggested include direct phototoxicity by voriconazole or one of its metabolites (4) , oxidative stress pathway activation (5) , an indirect retinoid effect, or DNA damage repair inhibition (6) . This article is protected by copyright. All rights reserved.
No takes yet. Share an insight, caveat, or question.
Mansh et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: